跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,195 条关于
“ALDH1A1-targeted radiotheranostics”
全部
13,195
临床试验
4,229
药物
703
机构
46
资讯
8,217
12个月前
Nuclide Therapeutics Secures £5M to Advance ALDH1A1-Targeted Radiotheranostics for Therapy-Resistant Cancers
去年
Navigo Proteins and SCK CEN Partner to Advance Terbium-161 Based Radiotheranostics
11个月前
NUCLIDIUM Secures US Patent Protection for Copper-Based FAP-Targeting Radiotheranostics Platform
8个月前
Oncodesign Precision Medicine and Navigo Proteins Terminate Radiotheranostics Collaboration
3个月前
Nuclidium Raises €115 Million to Advance Copper-Based Radiotheranostics for Prostate and Breast Cancer
去年
Nuclidium Raises $99M Series B to Advance Copper-Based Radiopharmaceutical Platform
去年
NUCLIDIUM's Copper-Based PET Tracer Shows Promise in Phase I/II Trial for Neuroendocrine Tumor Detection
去年
Starpharma Advances Dendrimer Drug Delivery Platform with Genentech Partnership and Clinical Progress
6个月前
Pentixapharm Receives FDA Approval for CXCR4-Targeted Radiotheranostic Program in Blood Cancers
2年前
IBI363 Receives FDA Designation, Advancing Treatment for Unspecified Condition
第 1 页，共 822 页
上一页
下一页
